Partners

Founded by brigham and women's hospital and massachusetts general hospital

Office of Continuing Professional Development

ASH 2017 Highlights

new DFBWCC logo.jpg

Thank you for your interest in the continuing education program: ASH 2017 Highlights CME. Online registration is now closed. If you're still interested in attending, we are accepting on-site registrations on Saturday morning, January 6th, beginning at 7:30 am.

Saturday, January 6, 2018
7:30 a.m. - 2:15 p.m.

Boston Marriott Newton Hotel
2345 Commonwealth Avenue
Newton, MA 02466

Description

The care of patients with hematologic malignancies is evolving rapidly. This continuing medical education activity will discuss new developments in the diagnosis and treatment of hematologic malignancies, as presented at the 2017 Annual Meeting of the American Society of Hematology (ASH).

At this one-day course, faculty will share the latest updates in lymphoma, leukemia, multiple myeloma, coagulation disorders, and stem cell transplantation. Through case-based presentations and Q&A, attendees will gain a deeper understanding of emerging treatments available for blood cancers and blood disorders and learn how these new therapies can be integrated into daily practice.

Learning Objectives

At the conclusion of this course, attendees will be able to:
1. Provide an overview and highlight the recent medical advances presented at the 2017 Annual Meeting of the American Society of Hematology, which will help physicians achieve better patient outcomes; and
2. Recognize appropriate management and treatment options for hematologic malignancies and utilize these approaches in routine clinical practice.

Target Audience

This activity is directed toward hematologists, medical oncologists, internists, nurse practitioners, oncology nurses, and other interested healthcare providers.

Agenda

7:30 am

Registration Check-in and Continental Breakfast

8:00

Welcome and Introduction
Robert J. Soiffer, MD

8:15

Chronic Lymphocytic Leukemia (CLL)
Matthew S. Davids, MD

9:00

Lymphoma
Ann S. LaCasce, MD, MMSc

9:30

Coagulation
Jean M. Connors, MD

10:00

Break

10:15

Stem Cell Transplantation
Corey S. Cutler, MD, MPH, FRCPC

11:15

SystemicMastocytosis, Acute Lymphocytic Leukemia (ALL) and Chronic Myelogenous Leukemia (CML)
Daniel J. DeAngelo, MD, PhD

12:00 pm

Working Lunch:CAR T-Cell Therapy
Caron Jacobson, MD

1:00

Multiple Myeloma
Paul G. Richardson, MD

1:45

Acute Myeloid Leukemia (AML),
Acute Promyelocytic Leukemia (APL), and

Myelodysplastic Syndrome (MDS)
Richard M. Stone, MD

2:15

Closing Remarks

Please note: program changes/substitutions may be made without notice

Faculty

Robert J. Soiffer, MD-Course Director
Chair, Executive Committee for Clinical Programs,
Vice Chair, Department of Medical Oncology,
Chief, Division of Hematologic Malignancies,
Co-Chief, Adult Stem Cell Transplantation Program,
Dana-Farber/Brigham and Women's Cancer Center;
Professor of Medicine, Harvard Medical School


Jean M. Connors, MD
Medical Director, Anticoagulation Management Service,
Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Medicine, Harvard Medical School

Corey S. Cutler, MD, MPH, FRCPC
Medical Oncologist, Stem Cell Transplantation Program,
Dana-Farber/Brigham and Women's Cancer Center;
Associate Professor of Medicine, Harvard Medical School

Matthew S. Davids, MD, MMSc
Associate Director, Center for Chronic Lymphocytic Leukemia,
Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Medicine, Harvard Medical School

Daniel J. DeAngelo, MD, PhD
Director, Clinical and Translational Research,
Adult Leukemia Program,
Dana-Farber/Brigham and Women's Cancer Center;
Associate Professor of Medicine, Harvard Medical School

Caron Jacobson, MD
Assistant Professor of Medicine,
Harvard Medical School.
Lymphoma Physician,
Medical Director, Immune Effector Cell Therapy Program
Dana-Farber Cancer Institue.

Ann S. LaCasce, MD, MMSc
Director, Dana-Farber/Partners CancerCare Hematology-Medical
Oncology Fellowship Program,
Medical Oncologist, Adult Lymphoma Program,
Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Medicine, Harvard Medical School

Paul G. Richardson, MD
Clinical Program Leader and Director of Clinical Research,
Jerome Lipper Multiple Myeloma Center,
Dana-Farber/Brigham and Women's Cancer Center;
Professor of Medicine, Harvard Medical School

Richard M. Stone, MD
Chief of Staff, Dana-Farber Cancer Institute;
Program Director, Adult Leukemia Program,
Dana-Farber/Brigham and Women's Cancer Center;
Professor of Medicine, Harvard Medical School

Additional Information

ABOUT THE CENTER FOR HEMATOLOGIC ONCOLOGY ATDANA-FARBER/BRIGHAM AND WOMEN'S CANCER CENTER

We offer advanced, specialized care for patients with all types of hematologic malignancies, including leukemia and similar bone marrow disorders, lymphoma, multiple myeloma, Waldenstrom's macroglobulinemia, and other related blood disorders.

Dana-Farber/Brigham and Women's Cancer Center is at the forefront of stem cell transplantation, performing more than 500 transplants each year. Our team of specialists are national leaders in basic and clinical research designed to bring cutting-edge, innovative therapies to patients with blood cancers. The program is committed to working closely with referring oncologists to jointly devise clinical strategies to improve the care of our patients.

Registration Fees

Registration Fee:
(non-refundable, includes course materials, continental breakfast, lunch, and complimentary parking):

- $75.00 through December 26, 2017
- $85.00 after December 26, 2017


Forms of Payment Accepted:

- Credit Card: Online
- Check: Mail-in/On-site

(Please note-: cash is not accepted)

Contact

For questions regarding registration or CME information, please contact the Partners Office of Continuing Professional Development at partnerscpd@partners.org or 857-282-2515.

For questions regarding the conference, please call 1-800-553-3787.

If you have any food allergies, or if you require accommodations such as an ASL interpreter, materials in an alternative format, or wheelchair access, please contact our course coordinator at kwooten@partners.org or call 1-800-553-3787 before the live event.

Location and Parking

This course will be held at the Boston Marriott Newton Hotel, 2345 Commonwealth Avenue, Newton, MA.

Provided by

Dana-Farber/Brigham and Women's Cancer Center and Partners HealthCare System

new DFBWCC logo.jpg

CME Information

ACCREDITATION

Physician Credits:
Partners HealthCare System is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Partners HealthCare System designates this live activity for a maximum of 6 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credits:
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 5 continuing education contact hours through the California Board of Registered Nursing.Certificates will be sent after completion of the evaluation.